Document is current
Any future updates will be listed below
-
Authors
Heels-Ansdell, Diane
Billot, Laurent
Thabane, Lehana
Alhazzani, Waleed
Deane, Adam
Guyatt, Gordon
Finfer, Simon
Lauzier, François
Myburgh, John
Young, Paul
Arabi, Yaseen
Marshall, John
English, Shane
Muscedere, John
Ostermann, Marlies
Venkatesh, Bala
Zytaruk, Nicole
Hardie, Miranda
Hammond, Naomi
Knowles, Serena
Saunders, Lois
Poole, Alexis
Al-Fares, Abdulrahman
Xie, Feng
Hall, Richard
Cook, Deborah http://orcid.org/0000-0002-4087-543X
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (202207CL3-492565-CTP-CEBA-19215, 201610PJT-378226-PJT-CEBA-18373)
National Health and Medical Research Council of Austraila (GNT1124675)
NIHR Clinical Research Network (CPMS ID 45782)
- License Information
-
More Information
Article History
Received: 23 May 2023
Accepted: 9 November 2023
First Online: 6 December 2023
Declarations
:
: REVISE is approved by Health Canada [HC6-24-c210404], Clinical Trials Ontario Research Ethics Project ID: 1360, the Northern Sydney Local Health District Human Research Ethics Committee (HREC) [2019/ETH08405], and Comissão Nacional de Ética em Pesquisa (CONEP) [5.734.590]. Regulatory oversight is by Health Canada [HC6-24-c210404]. All participating centers have local ethics approval.
: Not applicable for this statistical analysis plan.
: All authors are involved in the REVISE Trial in some capacity. Otherwise, the authors declare that they have no competing interests.
